CareRx Corp's stock has seen a notable uptick this week, with a 7.08% increase amid recent financial announcements.
CareRx Corp (CRRX.TO) has experienced an impressive week on the TSX, gaining 7.08% as investors react to recent financial results and dividend announcements. The stock closed at C$3.50, reflecting stability in the company's performance despite broader market conditions.
Advertisement
Earn cash back with a smarter spending account
Open a KOHO account and start earning on everyday purchases — no annual fee on the base plan.
CareRx Corp
CRRX.TO
CRRX.TO
CareRx Corp
WealthAwesomeMarket cap
$230.31M
P/E
8.6x
Div. yield
2.25%
Div. / share
$0.08
52W high
$3.95
52W low
$2.71
1W change
+7.08%
Beta
0.60
Analyst Price Targets
Based on analyst covering CRRX
Wall Street analysts forecast CRRX stock price to rise 41.7% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$5.14
+41.7% Upside
Current Price
C$3.63
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CRRX's historical volatility
30-Day Vol
22.6%
Annualized
90-Day Vol
26.0%
Annualized
Trend (90d)
-3.5%
Annualized drift
90d Mean
C$3.59
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$3.62 | C$3.34 – C$3.91 |
| 60 trading days | C$3.60 | C$3.23 – C$4.02 |
| 90 trading days | C$3.59 | C$3.13 – C$4.10 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors may find CareRx's recent financial performance and dividend declaration encouraging, particularly as the stock trades near its 52-week range. However, it’s essential to consider both the technical analysis and market sentiment before making any investment decisions.
CareRx Reports Financial Growth Amid Dividend Initiatives
The company's recent financial results for Q1 2026 highlighted increased revenue and adjusted EBITDA, along with a disciplined approach to capital allocation through dividend declarations.
Bull case
CareRx's recent financial results show an increase in revenue and adjusted EBITDA, which suggests strong operational performance. This could attract more investors and support future growth.
Bear case
Despite the positive financial results, the stock is still down 6.44% year-to-date. This indicates potential challenges ahead that investors should keep an eye on.
Recent Price Action
CareRx Corp's stock closed at C$3.50, marking a 1D change of +0.00% and a 1W increase of +7.08%. The stock has shown resilience, with a monthly gain of 4.31%, although it remains down 6.44% year-to-date.
Company News and Financial Highlights
Advertisement
CareRx recently announced its Q1 2026 financial results, revealing increased revenue and adjusted EBITDA. These results, coupled with the declaration of a CAD$0.02 dividend per share payable on July 9, 2026, reflect a strategic approach to capital allocation and may enhance shareholder confidence.
Technical Picture
In terms of technical analysis, CareRx is currently trading above its 50-day moving average of C$3.35, indicating a positive short-term trend. However, it is slightly below its 200-day moving average of C$3.61. The stock has a 52-week range of C$2.71 to C$3.95, operating at 64% of this range. With a beta of 0.60, the stock is considered less volatile than the market. Notably, the latest trading volume of 27,257 shares is significantly higher than the 20-day average volume of 7,515 shares, suggesting increased investor interest.
Insider Activity
No recent insider activity has been reported for CareRx Corp, indicating a stable insider sentiment at this time.
Conclusion
CareRx Corp's stock closed at C$3.50, reflecting a stable position in the market. With positive financial results and a dividend declaration, the outlook appears bullish, although investors should remain cautious given the year-to-date decline.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
